Case 1 – Multidisciplinary treatment of a giant cell tumor of the bone affecting the sacrum of a young woman
Authors
Lorenzo D’Ambrosio
University of Torino, Department of Oncology, Orbassano (To), Italy.
Paola Boccone
University of Torino, Department of Oncology, Orbassano (To), Italy.
Pietro Pellegrino
Department of Orthopaedic Oncology and Reconstructive Surgery, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, CTO Hospital, Torino, Italy.
Sara Miano
University of Torino, Department of Oncology, Orbassano (To), Italy.
Ilaria Bertotto
Radiology Unit, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (To), Italy.
Antonio Manca
Interventional Radiology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (To), Italy.
Alberto Pisacane
Pathology Unit, Division of Medical Oncology, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (To), Italy.
Giovanni Grignani
University of Torino, Department of Oncology, Orbassano (To), Italy.
Raimondo Piana
Department of Orthopaedic Oncology and Reconstructive Surgery, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, CTO Hospital, Torino, Italy.
Piotr Rutkowski
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
denosumab, giant cell tumor of the bone, multidiscipinary management
Abstract
Giant cell tumor (GCT) of the bone is a benign but locally aggressive tumor arising in the bones. The sacrum represents the most common involved site of the spine. At this level GCT might cause relevant neurological deficits and/or impair activities of daily living. The mainstay of treatment is still represented by the adequate removal of the tumor limiting at the same time the impact of surgery. However, GCT may relapse or present in “difficult” locations or with very large destructive lesions that may not be operated preserving the function of the involved bone. In this scenario, subcutaneous administration of denosumab, a fully-humanized monoclonal antibody specifically directed against RANK-L, can reduce surgical risks and invasiveness improving outcomes. Here we present the case of a young lady affected by a large GCT of the sacrum that emphasizes the importance of the multidisciplinary management of this disease taking into account patient’s preferences.